US Equestrian Releases New Guidance for Cetirizine and Methocarbamol
| July 27, 2026
US Equestrian has been monitoring the use of two commonly-used therapeutic medications – cetirizine (commonly known by the brand name of the human product Zyrtec), and methocarbamol (commonly known by the brand name Robaxin) -- taking into account member questions and concerns about those substances. Effective immediately, cetirizine will become a permitted substance and may be used in competition. Previously, cetirizine had been treated as a prohibited medication, meaning competitors had...









